Kimber Ian, Stone Sue, Dearman Rebecca J
Syngenta Central Toxicology Laboratory, Macclesfield, Cheshire, United Kingdom.
Environ Health Perspect. 2003 Feb;111(2):227-31. doi: 10.1289/ehp.5703.
There is considerable interest in the design of approaches that will permit the accurate identification and characterization of proteins that have the inherent potential to induce sensitization and cause food allergy. Among the methods used currently as part of such assessments are consideration of structural similarity to, or amino acid sequence homology with, known human allergens; whether there exists immunologic cross-reactivity with known allergens; and measurement of resistance to proteolytic digestion in a simulated gastric fluid. Although such approaches provide information that will contribute to a safety assessment, they do not--either individually or collectively--provide a direct evaluation of the ability of a novel protein to cause allergic sensitization. For this reason, work is in progress to design and evaluate suitable animal models that will provide a more holistic assessment of allergenic potential. In this laboratory, the approach we have taken has been to examine the characteristics of immune responses induced in mice following parenteral (intraperitoneal) exposure to test proteins. The basis of this method is to determine simultaneously the overall immunogenic potential of proteins [measured as a function of immunoglobulin (Ig) G antibody responses] and to compare this with their ability to provoke IgE antibody production, IgE being the antibody that effects allergic sensitization. Although this approach has not yet been evaluated fully, the results available to date suggest that it will be possible to distinguish proteins that have the inherent potential to induce allergic sensitization from those that do not. In this article we summarize progress to date in the context of the scientific background against which such methods are being developed.
人们对设计一些方法有着浓厚的兴趣,这些方法能够准确识别和表征具有引发致敏和导致食物过敏内在潜力的蛋白质。目前作为此类评估一部分所使用的方法包括考虑与已知人类过敏原的结构相似性或氨基酸序列同源性;是否与已知过敏原存在免疫交叉反应;以及在模拟胃液中对蛋白水解消化的抗性测量。尽管这些方法提供了有助于安全评估的信息,但它们无论是单独还是综合起来,都无法直接评估一种新型蛋白质引发过敏致敏的能力。因此,正在开展工作来设计和评估合适的动物模型,以便对致敏潜力进行更全面的评估。在本实验室中,我们采用的方法是研究小鼠经肠胃外(腹腔内)接触测试蛋白后诱导的免疫反应特征。该方法的基础是同时确定蛋白质的整体免疫原性潜力(以免疫球蛋白(Ig)G抗体反应为函数进行测量),并将其与引发IgE抗体产生的能力进行比较,IgE是引发过敏致敏的抗体。尽管这种方法尚未得到充分评估,但迄今为止获得的结果表明,有可能区分出具有引发过敏致敏内在潜力的蛋白质和不具有这种潜力的蛋白质。在本文中,我们在开发此类方法的科学背景下总结了迄今为止所取得的进展。